Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT) - Study 2
Phase 3
Completed
- Conditions
- Otitis Media With Effusion in ChildrenOtitis Media Recurrent
- Interventions
- Drug: EXE844 Sterile Otic Suspension, 0.3%Procedure: Tympanostomy Tube Insertion
- First Posted Date
- 2015-05-06
- Last Posted Date
- 2018-07-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 404
- Registration Number
- NCT02436304
Efficacy and Safety of RTH258 Versus Aflibercept - Study 2
Phase 3
Completed
- Conditions
- Neovascular Age-Related Macular DegenerationChoroidal Neovascularization
- Interventions
- First Posted Date
- 2015-05-05
- Last Posted Date
- 2025-01-16
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 1048
- Registration Number
- NCT02434328
Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT)
Phase 3
Completed
- Conditions
- Otitis Media With Effusion in ChildrenOtitis Media Recurrent
- Interventions
- Drug: EXE844 Sterile Otic Suspension, 0.3%Procedure: Tympanostomy Tube Insertion
- First Posted Date
- 2015-05-01
- Last Posted Date
- 2018-07-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 470
- Registration Number
- NCT02432105
SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)
Phase 4
Completed
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- Interventions
- Drug: Brinz/brim vehicleDrug: Prostaglandin analogue
- First Posted Date
- 2015-04-17
- Last Posted Date
- 2018-11-15
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 290
- Registration Number
- NCT02419508
- Locations
- 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Clear Care® Plus vs. PeroxiClear™
Not Applicable
Completed
- Conditions
- Refractive Error
- Interventions
- Device: Clear Care Plus contact lens solutionDevice: PeroxiClear contact lens solutionDevice: Silicone hydrogel contact lenses
- First Posted Date
- 2015-04-09
- Last Posted Date
- 2016-09-19
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 133
- Registration Number
- NCT02413333
DAILIES® AquaComfort Plus® Multifocal (MF) - Comparative Assessment of Visual Performance
Not Applicable
Completed
- Conditions
- Presbyopia
- Interventions
- Device: DACP MFDevice: PROCLEAR 1D MF
- First Posted Date
- 2015-03-31
- Last Posted Date
- 2016-08-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 70
- Registration Number
- NCT02403180
Lubricity Post-Wear - Competitive Lenses Pilot
Not Applicable
Completed
- Conditions
- Refractive Error
- Interventions
- Device: Narafilcon A contact lensesDevice: Stenfilcon A contact lensesDevice: Somofilcon A contact lenses
- First Posted Date
- 2015-03-30
- Last Posted Date
- 2016-09-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 24
- Registration Number
- NCT02402127
Safety Tolerability and Efficacy of Intravitreal LMG324 in the Treatment of Neovascular Age-Related Macular Degeneration
Phase 1
Terminated
- Conditions
- Age-related Macular Degeneration (AMD)
- Interventions
- Biological: LMG324Biological: Ranibizumab 0.5 mgBiological: Sham
- First Posted Date
- 2015-03-25
- Last Posted Date
- 2019-06-05
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 25
- Registration Number
- NCT02398500
- Locations
- 🇺🇸
Call Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
A Real-World Registry to Investigate the Performance of LenSx® Laser in Chinese Patients
Completed
- Conditions
- Cataracts
- Interventions
- Device: LenSx® Laser
- First Posted Date
- 2015-03-24
- Last Posted Date
- 2016-06-06
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 1541
- Registration Number
- NCT02396719
- Locations
- 🇨🇳
Alcon China Ophthalmic Product Co., Ltd., Beijing, China
Clinical Evaluation of MyDay™ and 1-DAY ACUVUE® TruEye®
Not Applicable
Completed
- Conditions
- Refractive Error
- Interventions
- Device: Stenfilcon A contact lensesDevice: Narafilcon A contact lenses
- First Posted Date
- 2015-03-17
- Last Posted Date
- 2016-12-05
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 66
- Registration Number
- NCT02388763
© Copyright 2025. All Rights Reserved by MedPath